메뉴 건너뛰기




Volumn , Issue , 2007, Pages 451-492

Solid dispersion technologies

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84971329242     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (7)

References (72)
  • 1
    • 0028948839 scopus 로고
    • Theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon GL, Lennernas H, Shah VP, Crison JR. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12(3):413–20.
    • (1995) Pharm Res , vol.12 , Issue.3 , pp. 413-420
    • Amidon, G.L.1    Lennernas, H.2    Shah, V.P.3    Crison, J.R.4
  • 2
    • 0002510887 scopus 로고    scopus 로고
    • Avoiding investment in doomed drugs, is poor solubility an industry wide problem?
    • Lipinski CA. Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr Drug Dis 2001; 4:17–9.
    • (2001) Curr Drug Dis , vol.4 , pp. 17-19
    • Lipinski, C.A.1
  • 3
    • 0345468942 scopus 로고    scopus 로고
    • Disperse Systems
    • Banker GS, Rhodes CT, eds., 3rd edn. New York, NY: Marcel Dekker, Inc
    • Tabibi SE, Rhodes CT. Disperse Systems. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 3rd edn. New York, NY: Marcel Dekker, Inc.; 1996: 299–331.
    • (1996) Modern Pharmaceutics , pp. 299-331
    • Tabibi, S.E.1    Rhodes, C.T.2
  • 4
    • 0037151528 scopus 로고    scopus 로고
    • A novel particle engineering technology: Spray-freezing into liquid
    • Rogers TL, Hu JH, Yu ZS, Johnston KP, Williams III RO. A novel particle engineering technology: spray-freezing into liquid. Int J Pharm 2002; 242(1–2): 93–100.
    • (2002) Int J Pharm , vol.242 , Issue.1-2 , pp. 93-100
    • Rogers, T.L.1    Hu, J.H.2    Yu, Z.S.3    Johnston, K.P.4    Williams, R.O.5
  • 5
    • 1842559836 scopus 로고    scopus 로고
    • Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs
    • Hu J, Johnston KP, Williams III RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004; 30(3):233–45.
    • (2004) Drug Dev Ind Pharm , vol.30 , Issue.3 , pp. 233-245
    • Hu, J.1    Johnston, K.P.2    Williams, R.O.3
  • 6
    • 0034601240 scopus 로고    scopus 로고
    • Improving drug solubility for oral delivery using solid dispersions
    • Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharma Biopharm 2000; 50(1):47–60.
    • (2000) Eur J Pharma Biopharm , vol.50 , Issue.1 , pp. 47-60
    • Leuner, C.1    Dressman, J.2
  • 7
    • 0001927169 scopus 로고    scopus 로고
    • Supercritical antisolvent precipitation of micro-and nano-particles
    • Reverchon E. Supercritical antisolvent precipitation of micro-and nano-particles. J Supercrit Fluids 1999; 15(1):1–21.
    • (1999) J Supercrit Fluids , vol.15 , Issue.1 , pp. 1-21
    • Reverchon, E.1
  • 8
    • 0032771526 scopus 로고    scopus 로고
    • Phase behavioral effects on particle formation processes using supercritical fluids
    • Palakodaty S, York P. Phase behavioral effects on particle formation processes using supercritical fluids. Pharm Res 1999; 16(7):976–85.
    • (1999) Pharm Res , vol.16 , Issue.7 , pp. 976-985
    • Palakodaty, S.1    York, P.2
  • 9
    • 0001485045 scopus 로고
    • Production of fine powders by the rapid expansion of supercritical fluid solutions
    • Matson DW, Peterson RC, Smith RD. Production of fine powders by the rapid expansion of supercritical fluid solutions. Adv Ceramics 1987; 21:109.
    • (1987) Adv Ceramics , vol.21 , pp. 109
    • Matson, D.W.1    Peterson, R.C.2    Smith, R.D.3
  • 10
    • 0027333734 scopus 로고
    • Polymeric materials formed by precipitation with a compressed fluid antisolvent
    • Dixon DJ, Johnston KP, Bodmeier RA. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J 1993; 39:127–39.
    • (1993) Aiche J , vol.39 , pp. 127-139
    • Dixon, D.J.1    Johnston, K.P.2    Bodmeier, R.A.3
  • 11
    • 0025817407 scopus 로고
    • Atmospheric spray-freeze drying: A suitable alternative in freeze-drying technology
    • Mumenthaler M, Leuenberger H. Atmospheric spray-freeze drying: a suitable alternative in freeze-drying technology. Int J Pharm 1991; 72(2):97–110.
    • (1991) Int J Pharm , vol.72 , Issue.2 , pp. 97-110
    • Mumenthaler, M.1    Leuenberger, H.2
  • 12
    • 85022750938 scopus 로고
    • Briggs AR, Maxwell TJ, inventors; Process for Preparing Powder Blends
    • Briggs AR, Maxwell TJ, inventors; Process for Preparing Powder Blends. US Patent 3,721,725. 1973.
    • (1973) US Patent , vol.3 , Issue.721 , pp. 725
  • 15
    • 33847632965 scopus 로고    scopus 로고
    • Preparation of nanostructured particles of poorly water soluble drugs via a novel ultra-rapid freezing technology
    • Evans JC, Scherzer BD, Tocco CD, et al. Preparation of nanostructured particles of poorly water soluble drugs via a novel ultra-rapid freezing technology. Poly Mater Sci Eng (2003) 2003; 89:742.
    • (2003) Poly Mater Sci Eng (2003) , vol.89 , pp. 742
    • Evans, J.C.1    Scherzer, B.D.2    Tocco, C.D.3
  • 16
    • 0037373357 scopus 로고    scopus 로고
    • Properties of rapidly dissolving eutectic mixtures of poly(-ethylene glycol) and fenofibrate: The eutectic microstructure
    • Law D, Wang W, Schmitt EA, Qiu Y, Krill SL, Fort JJ. Properties of rapidly dissolving eutectic mixtures of poly(-ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci 2003; 92:505–15.
    • (2003) J Pharm Sci , vol.92 , pp. 505-515
    • Law, D.1    Wang, W.2    Schmitt, E.A.3    Qiu, Y.4    Krill, S.L.5    Fort, J.J.6
  • 17
    • 9744245294 scopus 로고    scopus 로고
    • A new fenofibrate formulation: Results of six single-dose, clinical studies of bioavailability under fed and fasting conditions
    • Guivarc’h P-H, Vachon MG, Fordyce D. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions. Clin Ther 2004; 26(9):1456–69.
    • (2004) Clin Ther , vol.26 , Issue.9 , pp. 1456-1469
    • Guivarc’H, P.-H.1    Vachon, M.G.2    Fordyce, D.3
  • 18
    • 19444375996 scopus 로고    scopus 로고
    • Enhancement of oral bioavailability of poorly water-soluble drugs by poly(Ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies
    • Sant VP, Smith D, Leroux J-C. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. J Control Release 2005; 104 (2):289–300.
    • (2005) J Control Release , vol.104 , Issue.2 , pp. 289-300
    • Sant, V.P.1    Smith, D.2    Leroux, J.-C.3
  • 19
    • 2942516895 scopus 로고    scopus 로고
    • Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: Preparation and characterization
    • Sant VP, Smith D, Leroux J-C. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. J Control Release 2004; 97(2):301-12.
    • (2004) J Control Release , vol.97 , Issue.2 , pp. 301-312
    • Sant, V.P.1    Smith, D.2    Leroux, J.-C.3
  • 20
    • 21244445440 scopus 로고    scopus 로고
    • Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: In vitro and in vivo evaluations
    • Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res 2005; 22(6):990–8.
    • (2005) Pharm Res , vol.22 , Issue.6 , pp. 990-998
    • Ambike, A.A.1    Mahadik, K.R.2    Paradkar, A.3
  • 21
    • 0036173224 scopus 로고    scopus 로고
    • Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate
    • Kinoshita M, Baba K, Nagayasu A, et al. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. J Pharm Sci 2002; 91(2):362–70.
    • (2002) J Pharm Sci , vol.91 , Issue.2 , pp. 362-370
    • Kinoshita, M.1    Baba, K.2    Nagayasu, A.3
  • 22
    • 1942434656 scopus 로고    scopus 로고
    • The use of three different solid dispersion formulations – melt extrusion, film-coated beads, and a glass thermoplastic system – to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor
    • Verreck G, Vandecruys R, De Conde V, Baert L, Peeters J, Brewster ME. The use of three different solid dispersion formulations – melt extrusion, film-coated beads, and a glass thermoplastic system – to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor. J Pharm Sci 2004; 93(5):1217–28.
    • (2004) J Pharm Sci , vol.93 , Issue.5 , pp. 1217-1228
    • Verreck, G.1    Vandecruys, R.2    de Conde, V.3    Baert, L.4    Peeters, J.5    Brewster, M.E.6
  • 23
    • 1942434691 scopus 로고    scopus 로고
    • Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system
    • Dannenfelser R-M, He H, Joshi Y, Bateman S, Serajuddin ATM. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004; 93(5):1165–75.
    • (2004) J Pharm Sci , vol.93 , Issue.5 , pp. 1165-1175
    • Dannenfelser, R.-M.1    He, H.2    Joshi, Y.3    Bateman, S.4    Serajuddin, A.T.M.5
  • 24
    • 0037422394 scopus 로고    scopus 로고
    • Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen
    • Levis KA, Lane ME, Corrigan OI. Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. Int J Pharm 2003; 6:49–59.
    • (2003) Int J Pharm , vol.6 , pp. 49-59
    • Levis, K.A.1    Lane, M.E.2    Corrigan, O.I.3
  • 26
    • 23944496082 scopus 로고    scopus 로고
    • Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: Relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations
    • Klueglich M, Ring A, Scheuerer S, et al. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol 2005; 45(9):1055–61.
    • (2005) J Clin Pharmacol , vol.45 , Issue.9 , pp. 1055-1061
    • Klueglich, M.1    Ring, A.2    Scheuerer, S.3
  • 27
    • 85056952695 scopus 로고    scopus 로고
    • Solid Solutions for Insoluble Substances
    • Spring/Summer
    • Lewis J. Solid Solutions for Insoluble Substances. Drug Delivery Report 2006; Spring/Summer:62–3.
    • (2006) Drug Delivery Report , pp. 62-63
    • Lewis, J.1
  • 29
    • 0024390397 scopus 로고
    • Therapeutically relevant differences in the pharmacokinetical and pharmceutical behavior of ibuprofen lysinate as compared to ibuprofen acid
    • Geisslinger G, Dietzel K, Bezler H, Nuernberg B, Brune K. Therapeutically relevant differences in the pharmacokinetical and pharmceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol 1989; 27:324–8.
    • (1989) Int J Clin Pharmacol Ther Toxicol , vol.27 , pp. 324-328
    • Geisslinger, G.1    Dietzel, K.2    Bezler, H.3    Nuernberg, B.4    Brune, K.5
  • 30
    • 84862448681 scopus 로고    scopus 로고
    • The discovery and characterization of selective cyclooxygenase-2 inhibitors
    • Bell R, Black L, Harries R, et al. The discovery and characterization of selective cyclooxygenase-2 inhibitors. Inflamm Res 2000; 49:S101.
    • (2000) Inflamm Res , vol.49 , pp. S101
    • Bell, R.1    Black, L.2    Harries, R.3
  • 31
    • 6944243071 scopus 로고    scopus 로고
    • Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68
    • Chen Y, Zhang GGZ, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 2004; 286(1–2):69–80.
    • (2004) Int J Pharm , vol.286 , Issue.1-2 , pp. 69-80
    • Chen, Y.1    Zhang, G.G.Z.2    Neilly, J.3    Marsh, K.4    Mawhinney, D.5    Sanzgiri, Y.D.6
  • 32
    • 85056971657 scopus 로고    scopus 로고
    • Washington, DC: American Pharmaceutical Association
    • Collett JH, Popli H. Poloxamer. Washington, DC: American Pharmaceutical Association; 2001.
    • (2001) Poloxamer
    • Collett, J.H.1    Popli, H.2
  • 33
    • 0031395859 scopus 로고    scopus 로고
    • Physicochemical characterizations of piroxicam-poloxamer solid dispersion
    • Shin SC, Cho CW. Physicochemical characterizations of piroxicam-poloxamer solid dispersion. Pharm Dev Tech 1997; 2:403–7.
    • (1997) Pharm Dev Tech , vol.2 , pp. 403-407
    • Shin, S.C.1    Cho, C.W.2
  • 35
    • 0028218199 scopus 로고
    • Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water-soluble cellulose polymers
    • Chowdary KPR, Babu KVVS. Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water-soluble cellulose polymers. Drug Dev Ind Pharm 1994; 20(5):799–813.
    • (1994) Drug Dev Ind Pharm , vol.20 , Issue.5 , pp. 799-813
    • Chowdary, K.P.R.1    Babu, K.V.V.S.2
  • 37
    • 0242320527 scopus 로고    scopus 로고
    • Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: In vitro and in vivo evaluation
    • Yuksel N, Karatas A, Ozkan Y, Savaser A, Ozkan SA, Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur J Pharma Biopharm 2003; 56(3):453–9.
    • (2003) Eur J Pharma Biopharm , vol.56 , Issue.3 , pp. 453-459
    • Yuksel, N.1    Karatas, A.2    Ozkan, Y.3    Savaser, A.4    Ozkan, S.A.5    Baykara, T.6
  • 38
    • 0026322580 scopus 로고
    • Improved bioavailability of a new oral preparation of medroxyprogesterone acetate
    • Etienne MC, Milano G, Rene N, et al. Improved bioavailability of a new oral preparation of medroxyprogesterone acetate. J Pharm Sci 1991; 80(12):1130–2.
    • (1991) J Pharm Sci , vol.80 , Issue.12 , pp. 1130-1132
    • Etienne, M.C.1    Milano, G.2    Rene, N.3
  • 41
    • 0021485703 scopus 로고
    • An evaluation of high-close medroxyprogesterone acetate therapy in women with advanced breast cancer
    • Johnson JR, Priestman IJ, Fotherby K, Kelly KA, Priestman SG. An evaluation of high-close medroxyprogesterone acetate therapy in women with advanced breast cancer. Br J Cancer 1984; 1984(50):363–6.
    • (1984) Br J Cancer , vol.1984 , Issue.50 , pp. 363-366
    • Johnson, J.R.1    Priestman, I.J.2    Fotherby, K.3    Kelly, K.A.4    Priestman, S.G.5
  • 42
    • 0028337031 scopus 로고
    • Improved oral absorption of enteric coprecipitates of a poorly soluble drug
    • Kondo N, Iwao T, Hirai K, et al. Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J Pharm Sci 1994; 83(4):566–70.
    • (1994) J Pharm Sci , vol.83 , Issue.4 , pp. 566-570
    • Kondo, N.1    Iwao, T.2    Hirai, K.3
  • 43
    • 0027421578 scopus 로고
    • Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals
    • Kondo N, Iwao T, Kikuchi M, et al. Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals. Biol Pharm Bull 1993; 16 (8):796–800.
    • (1993) Biol Pharm Bull , vol.16 , Issue.8 , pp. 796-800
    • Kondo, N.1    Iwao, T.2    Kikuchi, M.3
  • 47
    • 1542410398 scopus 로고    scopus 로고
    • Ritonavir-PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations
    • Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004; 93(3):563–70.
    • (2004) J Pharm Sci , vol.93 , Issue.3 , pp. 563-570
    • Law, D.1    Schmitt, E.A.2    Marsh, K.C.3
  • 48
    • 0034886795 scopus 로고    scopus 로고
    • Physicochemical considerations in the preparation of amorphous ritonavir/PEG 8000 solid dispersions
    • Law D, Krill SL, Schmitt EA, et al. Physicochemical considerations in the preparation of amorphous ritonavir/PEG 8000 solid dispersions. J Pharm Sci 2001; 90(8):1015–25.
    • (2001) J Pharm Sci , vol.90 , Issue.8 , pp. 1015-1025
    • Law, D.1    Krill, S.L.2    Schmitt, E.A.3
  • 49
    • 0033634987 scopus 로고    scopus 로고
    • The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds
    • Aungst BJ, Nguyen NH, Bulgarelli JP, Oates-Lenz K. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res 2000; 17: 1175–80.
    • (2000) Pharm Res , vol.17 , pp. 1175-1180
    • Aungst, B.J.1    Nguyen, N.H.2    Bulgarelli, J.P.3    Oates-Lenz, K.4
  • 50
    • 0343953614 scopus 로고    scopus 로고
    • Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: Effect of the particle size and nutritional state
    • De Jaeghere F, Allemann E, Kubel F, et al. Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J Control Release 2000; 68(2):291–8.
    • (2000) J Control Release , vol.68 , Issue.2 , pp. 291-298
    • de Jaeghere, F.1    Allemann, E.2    Kubel, F.3
  • 52
    • 19944432124 scopus 로고    scopus 로고
    • Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion
    • Six K, Daems T, de Hoon J, et al. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci 2005; 24(2-3): 179–86.
    • (2005) Eur J Pharm Sci , vol.24 , Issue.2-3 , pp. 179-186
    • Six, K.1    Daems, T.2    de Hoon, J.3
  • 53
    • 0036278959 scopus 로고    scopus 로고
    • Characterization of the interaction of 2-hydroxypropyl-B-cyclodextrin with itraconazole at pH 2, 4 and 7
    • Peeters J, Neeskens P, Tollenaere JP, Van Remoortere P, Brewster M. Characterization of the interaction of 2-hydroxypropyl-B-cyclodextrin with itraconazole at pH 2, 4 and 7. J Pharm Sci 2002; 91:1414–22.
    • (2002) J Pharm Sci , vol.91 , pp. 1414-1422
    • Peeters, J.1    Neeskens, P.2    Tollenaere, J.P.3    van Remoortere, P.4    Brewster, M.5
  • 55
    • 0026596106 scopus 로고
    • Clinical pharmacokinetics of albendazole in patients with brain cysticercosis
    • Jung H, Hurtado M, Sanchez M, Medina MY, Sotelo J. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. J Clin Pharmacol 1992; 32:28–31.
    • (1992) J Clin Pharmacol , vol.32 , pp. 28-31
    • Jung, H.1    Hurtado, M.2    Sanchez, M.3    Medina, M.Y.4    Sotelo, J.5
  • 57
    • 0032997934 scopus 로고    scopus 로고
    • Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique
    • Kohri N, Yamayoshi Y, Xin H, et al. Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 1999; 51(2):159–64.
    • (1999) J Pharm Pharmacol , vol.51 , Issue.2 , pp. 159-164
    • Kohri, N.1    Yamayoshi, Y.2    Xin, H.3
  • 58
    • 85056959391 scopus 로고    scopus 로고
    • Mosby’s Drug Consult. 16 edn. St. Louis, Missouri: Mosby
    • Maheswaran AM, ed
    • Maheswaran AM, ed. Mosby’s Drug Consult. 16 edn. St. Louis, Missouri: Mosby, Inc.; 2006.
    • (2006) Inc.
  • 59
    • 3843097202 scopus 로고    scopus 로고
    • Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
    • Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharma Biopharm 2004; 58(2):265–78.
    • (2004) Eur J Pharma Biopharm , vol.58 , Issue.2 , pp. 265-278
    • Lindenberg, M.1    Kopp, S.2    Dressman, J.B.3
  • 60
    • 33744974493 scopus 로고    scopus 로고
    • Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles
    • Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 2006; 317(1):61–8.
    • (2006) Int J Pharm , vol.317 , Issue.1 , pp. 61-68
    • Wong, S.M.1    Kellaway, I.W.2    Murdan, S.3
  • 61
    • 0009470340 scopus 로고
    • Physico-chemical properties of (–)-1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-allyl-1,14-dihy-droxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetrametyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9] octacos-18-ene-2,3,10,16-tetrone hydrate (FK-506)
    • Hane K, Fujioka M, Namiki Y, et al. Physico-chemical properties of (–)-1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R-17-allyl-1,14-dihy-droxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetrametyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9] octacos-18-ene-2,3,10,16-tetrone hydrate (FK-506). Iyakuhin Kenkyu 1992; 23: 33–43.
    • (1992) Iyakuhin Kenkyu , vol.23 , pp. 33-43
    • Hane, K.1    Fujioka, M.2    Namiki, Y.3
  • 63
    • 0242266530 scopus 로고    scopus 로고
    • Establishment of new preparation method for solid dispersion formulation of tacrolimus
    • Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 2003; 267 (1–2):79–91.
    • (2003) Int J Pharm , vol.267 , Issue.1-2 , pp. 79-91
    • Yamashita, K.1    Nakate, T.2    Okimoto, K.3
  • 66
    • 32344439711 scopus 로고    scopus 로고
    • Enhancing the Bioavailability of Cyclosporine A Using Solid Dispersion Containing Polyoxyethylene (40) Stearate
    • Liu C, Wu J, Shi B, Zhang Y, Gao T, Pei Y. Enhancing the Bioavailability of Cyclosporine A Using Solid Dispersion Containing Polyoxyethylene (40) Stearate. Drug Dev Ind Pharm 2006; 32(1):115–23.
    • (2006) Drug Dev Ind Pharm , vol.32 , Issue.1 , pp. 115-123
    • Liu, C.1    Wu, J.2    Shi, B.3    Zhang, Y.4    Gao, T.5    Pei, Y.6
  • 67
    • 33745590868 scopus 로고    scopus 로고
    • Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies
    • Vaughn JM, T. MJ, Crisp MT, Johnston KP, Williams RO, III. Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev Ind Pharm 2006; 32(5):559–67.
    • (2006) Drug Dev Ind Pharm , vol.32 , Issue.5 , pp. 559-567
    • Vaughn, J.M.1    Mj, T.2    Crisp, M.T.3    Johnston, K.P.4    Williams, R.O.5
  • 68
    • 0037189994 scopus 로고    scopus 로고
    • Enhanced drug dissolution using evaporative precipitation into aqueous solution
    • Sarkari M, Brown J, Chen XX, Swinnea S, Williams RO, Johnston KP. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm 2002; 243(1–2):17–31.
    • (2002) Int J Pharm , vol.243 , Issue.1-2 , pp. 17-31
    • Sarkari, M.1    Brown, J.2    Chen, X.X.3    Swinnea, S.4    Williams, R.O.5    Johnston, K.P.6
  • 69
    • 0021744110 scopus 로고
    • Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions
    • Yakou S, Umehara K, Sonobe T, Nagai T, Sugihara M, Fukuyama Y. Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions. Chem Pharm Bull 1984; 32(10):4130–6.
    • (1984) Chem Pharm Bull , vol.32 , Issue.10 , pp. 4130-4136
    • Yakou, S.1    Umehara, K.2    Sonobe, T.3    Nagai, T.4    Sugihara, M.5    Fukuyama, Y.6
  • 70
    • 0024604891 scopus 로고
    • The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions
    • Doherty C, York P. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions. J Pharm Pharmacol 1989; 41(2):73–8.
    • (1989) J Pharm Pharmacol , vol.41 , Issue.2 , pp. 73-78
    • Doherty, C.1    York, P.2
  • 71
    • 3142754096 scopus 로고    scopus 로고
    • In vitro and in vivo evaluation of glibenclamide in solid dispersion systems
    • Tashtoush BM, Al-Qashi ZS, Najib NM. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev Ind Pharm 2004; 30(6): 601–7.
    • (2004) Drug Dev Ind Pharm , vol.30 , Issue.6 , pp. 601-607
    • Tashtoush, B.M.1    Al-Qashi, Z.S.2    Najib, N.M.3
  • 72
    • 0032885450 scopus 로고    scopus 로고
    • Solid disperison of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs
    • Serajuddin ATM. Solid disperison of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999; 88(10):1058–66.
    • (1999) J Pharm Sci , vol.88 , Issue.10 , pp. 1058-1066
    • Serajuddin, A.T.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.